A Growing Focus on Rare Cancers in Phase I Trials

Phase 1 trials of investigational drug candidates in oncology are increasing, likely as a way of involving more patients with rare tumors.

from Latest articles from Cancer Therapy Advisor Lung Cancer https://ift.tt/2SuXXmS